Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.